Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.08 +0.06 (+2.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Accumulated Expenses (2024 - 2026)

Updated

Polaryx Therapeutics' Accumulated Expenses was $73,000 in Q2 2026, up 62.2% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Accumulated Expenses at Polaryx Therapeutics came in at $23,000, down 73.6% from FY2024.

  • In earlier years, Accumulated Expenses was $87,000 in FY2024.
  • The Q2 2026 figure marks the highest quarterly Accumulated Expenses since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Polaryx Therapeutics 100.69 Mn 76.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 73,000.00
Mar 31, 2026 45,000.00
Dec 31, 2025 23,000.00
Dec 31, 2024 87,000.00
API Access

Polaryx Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PLYX&period=max&api_key=YOUR_API_KEY